NZ755033B2 - Treatment of plants against disease - Google Patents
Treatment of plants against disease Download PDFInfo
- Publication number
- NZ755033B2 NZ755033B2 NZ755033A NZ75503319A NZ755033B2 NZ 755033 B2 NZ755033 B2 NZ 755033B2 NZ 755033 A NZ755033 A NZ 755033A NZ 75503319 A NZ75503319 A NZ 75503319A NZ 755033 B2 NZ755033 B2 NZ 755033B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- acid
- silicate
- plant
- fatty acid
- xanthomonas
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title claims abstract description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 23
- 238000011282 treatment Methods 0.000 title description 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 28
- 239000000194 fatty acid Substances 0.000 claims abstract description 28
- 229930195729 fatty acid Natural products 0.000 claims abstract description 28
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 24
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims abstract description 23
- 241000589634 Xanthomonas Species 0.000 claims abstract description 16
- 241000196324 Embryophyta Species 0.000 claims description 27
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 17
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 16
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 16
- 239000004111 Potassium silicate Substances 0.000 claims description 15
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 claims description 15
- 229910052913 potassium silicate Inorganic materials 0.000 claims description 15
- 235000019353 potassium silicate Nutrition 0.000 claims description 15
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 14
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 13
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims description 13
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 13
- 239000000344 soap Substances 0.000 claims description 12
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 10
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 10
- 241000589649 Xanthomonas campestris pv. campestris Species 0.000 claims description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 235000013311 vegetables Nutrition 0.000 claims description 7
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 6
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims description 6
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 6
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 6
- 239000005639 Lauric acid Substances 0.000 claims description 6
- 235000021360 Myristic acid Nutrition 0.000 claims description 6
- 239000005642 Oleic acid Substances 0.000 claims description 6
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 6
- 235000021314 Palmitic acid Nutrition 0.000 claims description 6
- 235000021355 Stearic acid Nutrition 0.000 claims description 6
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 6
- 235000020778 linoleic acid Nutrition 0.000 claims description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 6
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 6
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000008117 stearic acid Substances 0.000 claims description 6
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 5
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 5
- 235000013339 cereals Nutrition 0.000 claims description 5
- 229960004488 linolenic acid Drugs 0.000 claims description 5
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 5
- 229960002446 octanoic acid Drugs 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 235000019197 fats Nutrition 0.000 claims description 4
- 235000002566 Capsicum Nutrition 0.000 claims description 3
- 241000207199 Citrus Species 0.000 claims description 3
- 240000005979 Hordeum vulgare Species 0.000 claims description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 240000003768 Solanum lycopersicum Species 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims description 3
- 235000020971 citrus fruits Nutrition 0.000 claims description 3
- 235000014571 nuts Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 240000006108 Allium ampeloprasum Species 0.000 claims description 2
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 2
- 244000291564 Allium cepa Species 0.000 claims description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 2
- 235000007319 Avena orientalis Nutrition 0.000 claims description 2
- 244000075850 Avena orientalis Species 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000218993 Begonia Species 0.000 claims description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 2
- 241000335053 Beta vulgaris Species 0.000 claims description 2
- 241000167854 Bourreria succulenta Species 0.000 claims description 2
- 241000219198 Brassica Species 0.000 claims description 2
- 235000011331 Brassica Nutrition 0.000 claims description 2
- 240000008574 Capsicum frutescens Species 0.000 claims description 2
- 235000002568 Capsicum frutescens Nutrition 0.000 claims description 2
- 244000193629 Cyphomandra crassifolia Species 0.000 claims description 2
- 235000000298 Cyphomandra crassifolia Nutrition 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 240000002395 Euphorbia pulcherrima Species 0.000 claims description 2
- 241000208152 Geranium Species 0.000 claims description 2
- 240000008669 Hedera helix Species 0.000 claims description 2
- 244000017020 Ipomoea batatas Species 0.000 claims description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 2
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 2
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 240000004713 Pisum sativum Species 0.000 claims description 2
- 235000010582 Pisum sativum Nutrition 0.000 claims description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 2
- 244000018633 Prunus armeniaca Species 0.000 claims description 2
- 240000005809 Prunus persica Species 0.000 claims description 2
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 244000017714 Prunus persica var. nucipersica Species 0.000 claims description 2
- 244000294611 Punica granatum Species 0.000 claims description 2
- 235000014360 Punica granatum Nutrition 0.000 claims description 2
- 241000109329 Rosa xanthina Species 0.000 claims description 2
- 235000004789 Rosa xanthina Nutrition 0.000 claims description 2
- 239000004115 Sodium Silicate Substances 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 240000003829 Sorghum propinquum Species 0.000 claims description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000021028 berry Nutrition 0.000 claims description 2
- 239000001390 capsicum minimum Substances 0.000 claims description 2
- 235000019693 cherries Nutrition 0.000 claims description 2
- PAZHGORSDKKUPI-UHFFFAOYSA-N lithium metasilicate Chemical compound [Li+].[Li+].[O-][Si]([O-])=O PAZHGORSDKKUPI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052912 lithium silicate Inorganic materials 0.000 claims description 2
- 235000009973 maize Nutrition 0.000 claims description 2
- 235000021018 plums Nutrition 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims 2
- 244000052769 pathogen Species 0.000 abstract description 7
- 241000192142 Proteobacteria Species 0.000 abstract description 6
- 230000002411 adverse Effects 0.000 abstract description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 9
- 229910052700 potassium Inorganic materials 0.000 description 9
- 239000011591 potassium Substances 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229960005322 streptomycin Drugs 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- ZDRBJJNXJOSCLR-YZKQBBCCSA-N 2-amino-2-[(2r,3s,5s,6r)-5-amino-2-methyl-6-[(2r,3s,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxyoxan-3-yl]iminoacetic acid;hydron;chloride Chemical compound Cl.N[C@H]1C[C@H](N=C(N)C(O)=O)[C@@H](C)O[C@@H]1OC1[C@H](O)[C@@H](O)C(O)[C@H](O)[C@@H]1O ZDRBJJNXJOSCLR-YZKQBBCCSA-N 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 239000003568 Sodium, potassium and calcium salts of fatty acids Substances 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 235000013966 potassium salts of fatty acid Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Abstract
Averting plant diseases is an ongoing battle in the agricultural and horticultural industries. Some diseases are minor; however others such as Xanthomonas present a serious problem, causing significant adverse economic impact. It is an object of the invention to go at least some way towards addressing this or to provide the public with a useful choice. The invention comprises a method of treating a plant against disease resulting from pathogens of Proteobacteria (eg Xanthomonas), comprising applying to the plant fatty acid and silicate. ing this or to provide the public with a useful choice. The invention comprises a method of treating a plant against disease resulting from pathogens of Proteobacteria (eg Xanthomonas), comprising applying to the plant fatty acid and silicate.
Description
TITLE Treatment of plants against disease.
FIELD OF THE INVENTION A preferred form of the invention relates to the treatment of plants against disease caused by pathogens of Proteobacteria (for example Xanthomonas bacteria).
A particularly preferred form of the invention relates to the treatment of cruciferous vegetables and their plant parts to prevent or reduce infection by ‘black rot’ caused by Xanthomonas campestris pv. campestris.
BACKGROUND Averting plant diseases is an ongoing battle in the agricultural and horticultural industries. Some diseases are minor; however others such as Xanthomonas present a serious problem, causing significant adverse economic impact.
Xanthomonas species can cause cankers, bacterial spots and blights on leaves, stems, branches and fruits in a wide variety of plant species. Pathogenic species show high degrees of specificity and some are split into multiple pathovars, a species designation based on host specificity.
Diseases caused by Xanthomonas are of particular concern to growers of a wide range of crops including, but not limited to, cruciferous vegetables such as cabbage, broccoli, cauliflower etc., solanaceae vegetables such as tomatoes, peppers etc, tree crops such as citrus, stone fruits etc., nut crops such as walnut, hazelnut, etc, and grains such as wheat, barley or rice.
Spraying agricultural treatments is one of the more effective methods for managing infection by for the prevention or suppression of disease symptoms caused by Xanthomonas bacteria. They fall into three main groups depending on the plant to be treated and the circumstances of the infection.
Copper-based fungicides are commonly used to treat diseases caused by Xanthomonas, but in general they cannot be used long term as they may lead to undesirable levels of copper accumulating in the surrounding soil. Further, Xanthomonas bacteria can become too readily resistant to copper in certain crops, therefore requiring higher rates to keep control of the disease. Copper can also be quite toxic to certain important soil organisms.
There is a relatively limited range of antibiotics available for treatment of plant diseases, and their long-term use heightens the risk of plants becoming resistant to them. Additionally there are often objections to these treatments based on the fear of humans acquiring resistance to the antibiotics, ie through consuming food produced using them. Antibiotics commonly used for treating diseases caused by Xanthomonas comprise streptomycin and kasugamycin based products.
There are some so-called ‘soft’ pesticide alternatives that require no withholding period because of their lack of any significant residual toxicity. Many are in the category of ‘biologicals’, which are organisms that prevent or influence the disease, or elicit heightened plant resistance to the disease. In many cases, when they are tested against either copper or antibiotic applications, many biologicals or ‘elicitors’ fall short in terms of efficacy. In some cases their mode of action requires particular climatic conditions, which may or may not exist in the environment at hand.
OBJECT OF THE INVENTION It is an object of preferred embodiments of the invention to at least go some way towards averting plant diseases caused by pathogens of Proteobacteria, for example Xanthomonas bacteria, and particularly Xanthomonas campestris pv. camprestris.
While this object applies to preferred embodiments, it should not be seen as a limitation on any claims expressed more broadly. The object of the invention per se is simply to provide the public with a useful choice.
DEFINITIONS The term "comprising" or derivatives thereof, eg "comprises", if and when used in this document in relation to a combination of features should not be seen as excluding the option of additional unspecified features or steps. In other words, the term should not be interpreted in a limiting way.
SUMMARY OF THE INVENTION According to one aspect of the invention there is provided a method of treating a plant against disease resulting from pathogens of Proteobacteria, for example from Xanthomonas, comprising applying to the plant: • fatty acid; and • silicate.
Optionally the method comprises applying a composition comprising the fatty acid and the silicate.
Optionally the Xanthomonas is bacterial and comprises Xanthomonas campestris pv. campestris.
Optionally the fatty acid is in the form of soap.
Optionally the fatty acid comprise one or more of: • sodium salt; and • potassium salt.
Optionally the fatty acid is in solution or in suspension in water.
Optionally the fatty acid comprises fat of animal origin.
Optionally the fatty acid comprises oil of plant origin.
Optionally the fatty acid comprises fat and oil of plant or animal origin.
Optionally fatty acid comprises one or more of the following- • Caproic Acid • Caprylic Acid • Capric Acid • Lauric Acid • Myristic Acid • Palmitic Acid • Stearic Acid • Oleic Acid • Linoleic Acid • Linolenic Acid • Arachidic Acid Optionally fatty acid comprises one or more of the following*- • C6:0 : Caproic Acid • C8:0 : Caprylic Acid • C10:0 : Capric Acid • C12:0 : Lauric Acid • C14:0 : Myristic Acid • C16:0 : Palmitic Acid • C18:0 : Stearic Acid • C18:1 : Oleic Acid • C18:2 : Linoleic Acid • C18:3 : Linolenic Acid • C20:0 : Arachidic Acid * The number immediately following the "C" term notes the number of carbon atoms in the molecule, and the number immediately after that designates the number of double bonds in the carbon chain. So for example "C6:0 Caproic acid" indicates that the molecule has ‘6’ carbon atoms and ‘0’ double bonds.
Optionally the silicate is water soluble.
Optionally the silicate is in the form of metallic salt.
Optionally the silicate comprises one or more of: • potassium silicate; • sodium silicate; and • lithium silicate; Optionally the molar ratio of the silicate ranges from 2.0 to 3.3. By way of example, if the silicate is potassium silicate and the molar ratio is 2.0, this means it contains 2.0 mol of SiO for every 1 mol of K O. And if the silicate is potassium silicate at a molar ratio of 3.3, it contains 3.3 mol of SiO for every 1 mol of K O.
Optionally the plant comprises one or more of a fruit, vegetable, nut, flower, grain or tree.
Optionally the fruit comprises one or more of citrus, peaches, nectarines, apricots, plums, cherries, tamarillos, pomegranates and berry fruit.
Optionally the vegetable comprises one or more of lettuce, brassicas, cucurbits, tomato, capsicum, chili, potato, sweet potato, carrots, beet, spring onions, leeks, beans and peas.
Optionally the grain comprises one or more of wheat, maize, sorghum, oats, rice and barley.
Optionally the tree comprises an ornamental variety selected from one or more of begonia, roses, ivy, geranium and poinsettia.
According to a further aspect, the invention comprises the use of: • fatty acid; and • silicate; in the preparation of a composition for treating a plant against disease resulting from pathogens of Proteobacteria, for example from Xanthomonas (eg Xanthomonas campestris pv. Campestris). Preferably the fatty acid and/or silicate and/or plant are as per any of the options set out above.
DRAWINGS Some preferred embodiments of the invention will now be described by way of example and with reference to the accompanying drawings, of which: Figures 1-7 graph, logarithmically, the bacterial count in the presence of solutions of potassium soap alone, potassium silicate alone and a number of concentrations of individual potassium soaps and potassium silicate, and the efficacy effect achieved by the various concentrations of potassium silicate to various concentrations of potassium soap when used against Xanthomonas campestris pv. campestris.
DETAILED DESCRIPTION In a preferred embodiment of the invention there is a composition for treating plants as above, against diseases as above. The composition is in the form of a solution for spraying, consisting of components as listed in the following examples.
Example 1 Component Amount Function 18.2 % w/v fatty acid 0.08 - 2L Active ingredient potassium salt in water (ie 182 g potassium salt of fatty acid per litre of water) A 44% w/v potassium 21.6 – 540 mL Active ingredient silicate water solution (ie (approximately 440 g potassium silicate per 80ppm to 2000ppm litre of water) Silica) Water 100L Diluent - solvent To produce the above composition, the silicate solution is added to about ¾ of the total water with stirring. The fatty acid potassium salt (in salt form) is then added with stirring. The balance of the water is then added with stirring.
The composition is in the form of a spray mixture ready to apply to plants by way of a manual or machine sprayer. Spraying is preferably liberal, such that excess composition runs off substantially all plant surfaces at critical plant growth stages, before disease occurs.
Example 2 The table below lists a number of specific prototype soap formulations produced in accordance with preferred embodiments of the invention.
Formulation Contents NS1 Potassium soap derived from fully refined, bleached and deodorised coconut oil (RBD Coconut Oil from Oilseed Products NZ Ltd).
NS2 Potassium soap derived from fully refined, bleached deodorised palm olein (RBD Palm Olein from Oilseed Products NZ Ltd).
The formulations NS1 and NS2 were produced by saponification. In this regard 1.63 kg of the oil component in each case was reacted with 420g of potassium hydroxide in 2.5L water. To assist the reaction, 360g of liquid potassium soap was added to the oil prior to the addition of the potassium hydroxide. The resulting concentrated solution was then buffered to a pH of approximately 10 using citric acid based buffer.
Approximately 5 L of water was then added to make each formulation up to a final volume of 10 L. The amount of potassium salt of fatty acid in each of the "NS" soap formulation came out at approximately 18% w/v, or in other words 180 g/L soap per litre of water.
The fatty acid profile for NS1 and NS2 are generally as follows: NS1 Proportion % w/w 0-1.0 • C6:0 : Caproic Acid • C8:0 : Caprylic Acid • C10:0 : Capric Acid 47.0 • C12:0 : Lauric Acid 18.0 • C14:0 : Myristic Acid • C16:0 : Palmitic Acid 9.0 • C18:0 : Stearic Acid • C18:1 : Oleic Acid • C18:2 : Linoleic Acid NS2 Proportion %w/w • C12:0 : Lauric Acid • 0-1.0 • C14:0 : Myristic Acid • 0.5-1.5 • C16:0 : Palmitic Acid • 37.0-42.0 • C18:0 : Stearic Acid • 3.0-5.5 • C18:1 : Oleic Acid • 40.0-45.0 • C18:2 : Linoleic Acid • 9.0-13.0 • C18:3 : Linolenic Acid • 0.0-1.0 • C20:0 : Arachidic Acid • 0.0-1.0 These NS1 and NS2 prototype soap formulations were used in a number of in-vitro studies, both individually and in combination with potassium silicate, as described below.
In Vitro Treatment of Xanthomonas campestris pv. campestris Laboratory trials were run to compare the effectiveness of certain embodiments of the invention against Xanthomonas campestris pv. campestris. The trial measured the bacterial count observed in the presence of the following test compositions: • NS1 and NS2 alone (each approximately 18% w/v potassium salts of fatty acids); • potassium silicate alone (concentration 44% w/v, molar ratio 2.2); • the combination of each ‘NS..’ component and silicate; • Kasugamycin (an industry standard antibiotic); • Streptomycin (an industry standard antibiotic) • Distilled water alone.
The test compositions are listed in the table below.
Product Units Treatment Rates Total NS1 L/100 L 0.08 0.4 1 2 4 NS2 L/100 L 0.08 0.4 1 2 4 Potassium silicate mL/100 L 21.6 108 270 540 4 L/100 L 0.08 0.08 0.08 0.08 0.4 0.4 0.4 0.4 1 1 1 1 2 2 2 2 NS1 + Potassium silicate 16 mL/100 L Potassium 21.6 108 270 540 21.6 108 270 540 21.6 108 270 540 21.6 108 270 540 silicate L/100 L NS2 + Potassium silicate 0.08 0.08 0.08 0.08 0.4 0.4 0.4 0.4 1 1 1 1 2 2 2 2 mL/100 L Potassium 21.6 108 270 540 21.6 108 270 540 21.6 108 270 540 21.6 108 270 540 silicate Water 1 2 Streptomycin g/100L 10.2 1 sulphate Kasumin (20 g/L L/100L 0.5 1 kasugamycin) Total Treatment Number 48 NS1, NS2 and the potassium silicate product were evaluated for their efficacy on an agar plate, in terms of their ability to control growth of Xanthomonas campestris pv. campestris at predetermined concentrations and combinations, a total of 53 treatments per replicate (see table above).
Two positive controls (Streptomycin and Kasumin (20g/L kasugamycin)) and a negative control (distilled water) were also included.
Each of the products was prepared to four times the required concentration. A 0.25 mL aliquot of each of these solutions was combined with 0.25 mL of potassium silicate (or water) and 0.5 mL of bacterial suspension making a total volume of 1 mL.
The solutions containing the products and bacteria were then incubated for 1 h at °C prior to diluting in a ten-fold series in sterile distilled water down to 10 . The diluted solutions were then plated to Casitone-yeast extract agar (CYE agar) (Araújo et al. 2012), and incubated at 20°C until individual bacterial colonies could be enumerated.
Each solution was separately made as three true replicates. Treatment means for each replicate were averaged over the three replicates. Treatments were randomized but not statistically analysed as the large number of zeros nullified the ANOVA model.
All data were presented on a logarithmic scale to enable differences in bacterial concentrations to be visualized.
In terms of disclosure, this document hereby discloses each item, feature or step mentioned herein in combination with one or more of any of the other item, feature or step disclosed herein, in each case regardless of whether such combination is claimed.
The bacterial colony count results for each sample are as shown at Figures 1-5.
While some preferred embodiments of the invention have been exemplified, it should be appreciated that modifications and improvements can occur without departing from the scope of the following claims.
Claims (18)
1. A method of treating a plant against disease resulting from Xanthomonas bacteria , comprising applying to the plant: 5 • fatty acid in the form of a soap; and • silicate. wherein the fatty acid is in solution or suspension in water.
2. A method according to claim 1, wherein the method comprises applying to the 10 plant a composition comprising the fatty acid and silicate.
3. A method according to claim 1 or 2, wherein the bacteria comprises
4.Xanthomonas campestris pv. campestris 15 4. A method according to any one of the preceding claims, wherein the fatty acid comprises one or more of: • sodium salt; and • potassium salt. 20
5. A method according to any one of the preceding claims, wherein the fatty acid comprises fat of animal origin.
6. A method according to any one of the preceding claims, wherein the fatty acid comprises oil of plant origin.
7. A method according to any one of the preceding claims, wherein fatty acid comprises fats and oil of plant or animal origin.
8. A method according to any one of the preceding claims, wherein the fatty acid 30 comprises one or more of the following- • Caproic Acid • Caprylic Acid • Capric Acid • Lauric Acid 35 • Myristic Acid • Palmitic Acid • Stearic Acid • Oleic Acid • Linoleic Acid • Linolenic Acid 5 • Arachidic Acid
9. A method according to any one of the preceding claims, wherein the fatty acid comprises one or more of the following- • C6:0 : Caproic Acid 10 • C8:0 : Caprylic Acid • C10:0 : Capric Acid • C12:0 : Lauric Acid • C14:0 : Myristic Acid • C16:0 : Palmitic Acid 15 • C18:0 : Stearic Acid • C18:1 : Oleic Acid • C18:2 : Linoleic Acid • C18:3 : Linolenic Acid • C20:0 : Arachidic Acid
10. A method according to any one of the preceding claims, wherein the silicate is water soluble.
11. A method according to any one of the preceding claims, wherein the silicate is 25 in the form of metallic salt.
12. A method according to any one of the preceding claims, wherein the silicate comprises one or more of: • potassium silicate; 30 • sodium silicate; • lithium silicate;
13. A method according to any one of the preceding claims, wherein the molar ratio of the silicate is from 2.0 to 3.3.
14. A method according to any one of the preceding claims, wherein the plant comprises one or more of a fruit, vegetable, nut, flower, grain and tree.
15. A method according to claim 12, wherein the fruit comprises one or more of 5 citrus, peaches, nectarines, apricots, plums, cherries, tamarillos, pomegranates and berry fruit.
16. A method according to claim 12, wherein the vegetable comprises one or more of lettuce, brassicas, cucurbits, tomato, capsicum, chili, potato, sweet potato, 10 carrots, beet, spring onions, leeks, beans and peas.
17. A method according to claim 12, wherein the grain comprises one or more of wheat, maize, sorghum, oats, rice and barley. 15
18. A method according to claim 12, wherein the plant comprises an ornamental variety selected from one or more of begonia, roses, ivy, geranium and poinsettia. Page 1 of 4
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ755033A NZ755033B2 (en) | 2019-07-01 | Treatment of plants against disease | |
US17/285,305 US20210315206A1 (en) | 2019-01-14 | 2019-09-16 | Treatment of Plants Against Disease |
AU2019422223A AU2019422223B2 (en) | 2019-01-14 | 2019-09-16 | Treatment of plants against disease. |
PCT/NZ2019/050124 WO2020149749A1 (en) | 2019-01-14 | 2019-09-16 | Treatment of plants against disease. |
EP19910494.4A EP3911160A4 (en) | 2019-01-14 | 2019-09-16 | Treatment of plants against disease |
BR112021010483-6A BR112021010483A2 (en) | 2019-01-14 | 2019-09-16 | Treatment of plants against diseases |
JP2021526249A JP2022518098A (en) | 2019-01-14 | 2019-09-16 | Plant treatment for disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ755033A NZ755033B2 (en) | 2019-07-01 | Treatment of plants against disease |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ755033A NZ755033A (en) | 2021-11-26 |
NZ755033B2 true NZ755033B2 (en) | 2022-03-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69914467T2 (en) | TREATMENT WITH PERSURIC ACIDS TO CONTROL PATHOGENIC ORGANISMS ON GROWING PLANTS | |
AU673496B2 (en) | Fatty acid based compositions for the control of established plant infections | |
Demir et al. | Effects of arbuscular mycorrhizal fungus, humic acid, and whey on wilt diseasecaused by Verticillium dahliae Kleb. in three solanaceous crops | |
MX2013004554A (en) | Synergistic activity of peracetic acid and at least one sar inducer for the control of pathogens in and onto growing plants. | |
AU2019422223B2 (en) | Treatment of plants against disease. | |
AU2019377010B2 (en) | Treatment of plants or fungi against disease | |
KR102473524B1 (en) | A composition containing a mixture containing at least fludioxonil and Aureobasidium pullulans strains | |
Omar et al. | Inhibition of the development of pathogenic fungi by extracts of some marine algae from the red sea of Jeddah, Saudi Arabia | |
NZ755033B2 (en) | Treatment of plants against disease | |
NZ755033A (en) | Treatment of plants against disease | |
Islam et al. | Effects of ε-polylysine and milk serum protein on the attachment and decontamination of Salmonella enteritidis on lettuce and radish sprouts | |
Ali et al. | Effect of some organic acids on growth, yield, oil production and enhancing anatomical changes to reduce fusarium wilt of Nigella sativa L | |
WO2021146155A1 (en) | Nontoxic coating concentrates for agricultural uses | |
NZ753590A (en) | Treatment of plants or fungi against disease | |
JPWO2020149749A5 (en) | ||
Argento et al. | Brassicas and their glucosinolate content for the biological control of root-knot nematodes in protected cultivation | |
US20190021331A1 (en) | Silver ion solution agricultural formulations | |
US20230124472A1 (en) | Nontoxic coating concentrates for agricultural uses | |
WO2011025395A1 (en) | Anti-phytopathogenic compositions | |
Ahmed et al. | Mitigating helminthosporium leaf spot disease in sesame: evaluating the efficacy of castor essential oil and sodium bicarbonate on disease management and crop yield enhancement | |
WO2023049163A1 (en) | Nontoxic coating concentrates for agricultural uses | |
Vaniya et al. | Green Molecules in Plant Health Management | |
ÖZDEMİR | The Search For Nature-Friendly Solution To Late Blight (Phytophtora Infestans) Disease | |
Etaware | Lipotoxicity and induced suppression of fungi associated with decay of melon seeds in Nigeria | |
JP2014237609A (en) | Control agent for rice plant seed infection disease damage |